Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists; Medicinal Research Reviews; Vol. 36, iss. 5

Bibliographic Details
Parent link:Medicinal Research Reviews
Vol. 36, iss. 5.— 2016.— [P. 871-923]
Corporate Author: Национальный исследовательский Томский политехнический университет Физико-технический институт Лаборатория № 31 ядерного реактора
Other Authors: Maslov L. N. Leonid Nikolaevich, Khaliulin I. G. Igor Germanovich, Oeltgen P. R. Peter, Naryzhnaya N. V. Nataliya Vladimirovna, Pei Jian-Ming, Brown Stephen, Lishmanov Yu. B. Yury Borisovich, Downey J. M. James
Summary:Title screen
It has now been demonstrated that the µ, δ 1, δ 2, and K 1 opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarct-reducing effect with prophylactic administration and prevent reperfusion-induced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemia-induced arrhythmias.
Режим доступа: по договору с организацией-держателем ресурса
Language:English
Published: 2016
Subjects:
Online Access:http://dx.doi.org/10.1002/med.21395
Format: Electronic Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=652384

MARC

LEADER 00000naa0a2200000 4500
001 652384
005 20250401100009.0
035 |a (RuTPU)RU\TPU\network\17668 
035 |a RU\TPU\network\15326 
090 |a 652384 
100 |a 20161220d2016 k||y0rusy50 ba 
101 0 |a eng 
102 |a US 
135 |a drgn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists  |f L. N. Maslov [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: p. 905-922 (333 tit.)] 
330 |a It has now been demonstrated that the µ, δ 1, δ 2, and K 1 opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarct-reducing effect with prophylactic administration and prevent reperfusion-induced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemia-induced arrhythmias. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 |t Medicinal Research Reviews 
463 |t Vol. 36, iss. 5  |v [P. 871-923]  |d 2016 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a opioids 
610 1 |a опиоиды 
610 1 |a ишемия 
610 1 |a реперфузия 
701 1 |a Maslov  |b L. N.  |g Leonid Nikolaevich 
701 1 |a Khaliulin  |b I. G.  |g Igor Germanovich 
701 1 |a Oeltgen  |b P. R.  |g Peter 
701 1 |a Naryzhnaya  |b N. V.  |g Nataliya Vladimirovna 
701 0 |a Pei Jian-Ming 
701 0 |a Brown Stephen 
701 1 |a Lishmanov  |b Yu. B.  |c specialist in the field of medical technology  |c lead engineer aof Tomsk Polytechnic University, doctor of medical sciences  |f 1951-  |g Yury Borisovich  |3 (RuTPU)RU\TPU\pers\34200  |9 17734 
701 1 |a Downey  |b J. M.  |g James 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Физико-технический институт  |b Лаборатория № 31 ядерного реактора  |3 (RuTPU)RU\TPU\col\20054  |9 27687 
801 2 |a RU  |b 63413507  |c 20161221  |g RCR 
856 4 |u http://dx.doi.org/10.1002/med.21395 
942 |c CF